Weight loss drugs and CMS coverage: Why all eyes are on Medicare
(By Rylee Wilson for Becker’s Hospital Review) New GLP-1 drugs to treat diabetes and obesity can be expensive, and most
Read More(By Rylee Wilson for Becker’s Hospital Review) New GLP-1 drugs to treat diabetes and obesity can be expensive, and most
Read More(Source – The Kaiser Family Foundation Published June 2023) Medicare provides health insurance coverage for more than 65 million people,
Read More(By Riz Hatton for Becker’s Hospital Review) Sixty-five percent of physicians plan to continue treating Medicare and Medicaid patients, according
Read More(By Kerry Dooley Young for STAT) For years, patients and medical groups have advocated for Medicare to cover wheelchairs with
Read More(By Jakob Emerson for Becker’s Hospital Review) CVS Health is expecting Aetna’s operating income to decrease by up to $1
Read More(By Rylee Wilson for Becker’s Hospital Review) Individuals who are dually eligible for Medicare and Medicaid had lower scores on
Read More(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read More(By Giles Bruce for Becker’s Hospital Review) Private insurance companies that contract for Medicare will continue to pay for remote
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing a set of rules for drug manufacturers, pharmaceutical benefit managers
Read More(By Bob Herman and Casey Ross for STAT) Senators warned the country’s largest Medicare Advantage insurers at a hearing on
Read More